BACKGROUND: Interactive voice response technology (IVR) allows investigators to collect daily measures of drinking, medication adherence, mood, and other treatment-relevant variables that may change day to day during a clinical trial. Despite these advantages, no published studies have used IVR in alcohol pharmacotherapy trials. METHODS: Subjects provided daily data via IVR during the 12-week treatment period. Seven subjects completed the trial. RESULTS: We found a high level of participant adherence to the IVR protocol, higher levels of drinking reported by IVR than by a commonly used recall method, and distinct within-day associations between daily mood and alcohol consumption: these could not be obtained through traditional assessment methods. CONCLUSIONS: IVR seems to be feasible for the collection of daily indicators of treatment outcomes and processes in pharmacotherapy studies among problem drinkers.
BACKGROUND: Interactive voice response technology (IVR) allows investigators to collect daily measures of drinking, medication adherence, mood, and other treatment-relevant variables that may change day to day during a clinical trial. Despite these advantages, no published studies have used IVR in alcohol pharmacotherapy trials. METHODS: Subjects provided daily data via IVR during the 12-week treatment period. Seven subjects completed the trial. RESULTS: We found a high level of participant adherence to the IVR protocol, higher levels of drinking reported by IVR than by a commonly used recall method, and distinct within-day associations between daily mood and alcohol consumption: these could not be obtained through traditional assessment methods. CONCLUSIONS: IVR seems to be feasible for the collection of daily indicators of treatment outcomes and processes in pharmacotherapy studies among problem drinkers.
Authors: Anne Buu; Runze Li; Maureen A Walton; Hanyu Yang; Marc A Zimmerman; Rebecca M Cunningham Journal: Subst Use Misuse Date: 2014-03-06 Impact factor: 2.164
Authors: Henry R Kranzler; Stephen Armeli; Reagan Wetherill; Richard Feinn; Howard Tennen; Joel Gelernter; Jonathan Covault; Timothy Pond Journal: Addict Biol Date: 2014-12-15 Impact factor: 4.280
Authors: Brent A Moore; Tera Fazzino; Declan T Barry; David A Fiellin; Christopher J Cutter; Richard S Schottenfeld; Samuel A Ball Journal: J Subst Abuse Treat Date: 2013-01-30
Authors: Jennifer W Tidey; Peter M Monti; Damaris J Rohsenow; Chad J Gwaltney; Robert Miranda; John E McGeary; James MacKillop; Robert M Swift; David B Abrams; Saul Shiffman; Jean A Paty Journal: Alcohol Clin Exp Res Date: 2007-11-20 Impact factor: 3.455